Tango Therapeutics, Inc. ( TNGX) - Stock Earnings
TNGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 15.9 million USD | 53.8 million USD |
| 2025Q4 | -38.7 million USD | — USD |
| 2026Q1 | -45.5 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
TNGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -101.7 million USD | 36.5 million USD |
| 2024 | -130.3 million USD | 42.1 million USD |
| 2025 | -101.6 million USD | 62.4 million USD |
| 2026 Est. | — | — |
TNGX
Price: $32.90
52 week price:
Earnings Per Share: -0.83 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179400
Market Capitalization: 2.6 billion